Onward. An email from Nick C: "I know you have been very bearish on Discovery Labs ( DSCO) in the past. Now that the company has gotten rid of
The FDA told Spectrum not to seek approval for its bladder cancer drug. Spectrum filed anyway but never told investors about the FDA warning.
An FDA committee said on Wednesday that Spectrum Pharmaceuticals' (SPPI) Qapzola drug for bladder tumors did not show substantial evidence of efficacy.